To clarify the specific molecular mechanism of FTO regulating the FAK signaling pathway and identify its downstream targets in NSCLC, a human m6A epitranscriptomic microarray was performed to map the m6A modifications in NSCLC. This evidence concerns the gene FTO and non-small cell lung carcinoma.